Circular Genomics partners with PharmatrophiX on circRNA biomarkers
Circular Genomics, Inc. and PharmatrophiX, Inc. announced a strategic biomarker collaboration to apply Circular Genomics’ blood-based circRNA profiling and analytics platform, CircPath, across PharmatrophiX’s LM11A-31 program and potentially its broader neurodegeneration pipeline. The in
<p>Circular Genomics, Inc. and PharmatrophiX, Inc. announced a strategic biomarker collaboration to apply Circular Genomics’ blood-based circRNA profiling and analytics platform, CircPath, across PharmatrophiX’s LM11A-31 program and potentially its broader neurodegeneration pipeline. The in</p>